Screener
IDEAYA Biosciences, Inc. IDYA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of property and equipment, net | (967) | (1,330) |
| Purchases of marketable securities | (42,610) | (105,207) |
| Maturities of marketable securities | 162,529 | 186,354 |
| Net cash provided by investing activities | 118,952 | 79,817 |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock related to at-the-market offering program, net of issuance costs | (9) | 25,009 |
| Proceeds from exercise of common stock options | 1,190 | 1,134 |
| Net cash provided by financing activities | 1,181 | 26,143 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s investing cash flow?
- IDEAYA Biosciences, Inc. (IDYA) reported investing cash flow of $118.95M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s investing cash flow changed year-over-year?
- IDEAYA Biosciences, Inc.'s investing cash flow increased by 49.0% year-over-year, from $79.82M to $118.95M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about IDEAYA Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude